Journal list menu
IssueCancer Communications: Volume 40, Issue 8
327-385August 2020
Export Citations
Download PDFs
ISSUE INFORMATION
REVIEW
Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy
- Pages: 329-344
- First Published: 12 July 2020
ORIGINAL ARTICLES
A phase I study of toripalimab, an anti-PD-1 antibody, in patients with refractory malignant solid tumors
- Pages: 345-354
- First Published: 26 June 2020
Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
- Pages: 355-369
- First Published: 01 July 2020
LETTERS TO THE EDITOR
Construction of an integrated prognostic classifier model for predicting the efficacy of immune checkpoint inhibitor therapy in non-small cell lung cancer
- Pages: 370-373
- First Published: 08 July 2020
Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors
- Pages: 374-379
- First Published: 15 July 2020
Ovarian cancer-excreted exosomal miR-199a-5p suppresses tumor metastasis by targeting hypoxia-inducible factor-2α in hypoxia microenvironment
- Pages: 380-385
- First Published: 19 May 2020
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)